Adacel-Polio 29 Unit

ADACEL-POLIO 29 Unit is a vaccine designed to protect against polio. This suspension is administered intramuscularly and is manufactured by Sanofi Pasteur Limited in Canada. It is commonly used for immunization against polio virus type 1 Mahoney.

ADACEL-POLIO 29 Unit is primarily used for the prevention of polio, a viral infection that can cause paralysis and other serious health complications. This vaccine is part of a broader immunization strategy to eradicate polio. It is often administered to individuals who have not previously received the polio vaccine or who require a booster dose.

Common effects of the ADACEL-POLIO vaccine may include mild soreness, redness, or swelling at the injection site. Some individuals may experience mild fever, fatigue, or headache. These effects are typically temporary and resolve within a few days.

ADACEL-POLIO should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to previous polio vaccines or any component of this vaccine should consult their healthcare provider before receiving it. It is important to inform the healthcare provider about any current illnesses or medications.

There are no specific known interactions with other medications, but it is always advisable to inform your healthcare provider about all medications and supplements you are taking. Alcohol and other substances generally do not interact with vaccines, but it is best to follow the advice of your healthcare provider.